Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Denso Corp. stock logo
DNZOY
Denso
$13.11
-1.6%
$13.07
$10.96
$16.58
$38.77B0.9877,309 shs124,747 shs
Oriental Land stock logo
OLCLY
Oriental Land
$21.84
-4.3%
$22.16
$18.37
$29.89
$41.09B0.6420,885 shs31,083 shs
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
$0.64
-0.6%
$0.53
$0.31
$0.77
$11.97B0.551,879 shs300 shs
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
$15.26
-0.7%
$15.03
$10.86
$19.88
$40.03B0.4686,391 shs72,140 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Denso Corp. stock logo
DNZOY
Denso
-1.58%-0.83%-0.38%-1.94%-13.06%
Oriental Land stock logo
OLCLY
Oriental Land
-4.29%-0.64%-1.36%+4.85%-22.80%
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
0.00%-9.57%+28.73%+50.28%+80.08%
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
-0.72%+1.53%+0.07%+2.90%+23.36%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Denso Corp. stock logo
DNZOY
Denso
N/AN/AN/AN/AN/AN/AN/AN/A
Oriental Land stock logo
OLCLY
Oriental Land
N/AN/AN/AN/AN/AN/AN/AN/A
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
1.6198 of 5 stars
0.03.02.50.01.40.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Denso Corp. stock logo
DNZOY
Denso
2.00
HoldN/AN/A
Oriental Land stock logo
OLCLY
Oriental Land
2.00
HoldN/AN/A
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
0.00
N/AN/AN/A
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SBMFF, OLCLY, SVNDY, and DNZOY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/14/2025
Denso Corp. stock logo
DNZOY
Denso
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
3/25/2025
Oriental Land stock logo
OLCLY
Oriental Land
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Denso Corp. stock logo
DNZOY
Denso
$47.03B0.81$1.77 per share7.40$11.77 per share1.11
Oriental Land stock logo
OLCLY
Oriental Land
$4.46B8.81$0.67 per share32.37$4.00 per share5.46
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/AN/A
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
$78.57B0.51$2.14 per share7.12$10.69 per share1.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Denso Corp. stock logo
DNZOY
Denso
$2.77B$0.9613.669.78N/A5.85%7.73%4.96%7/30/2025 (Estimated)
Oriental Land stock logo
OLCLY
Oriental Land
$815.34M$0.5043.6841.21N/A18.26%12.90%8.91%7/29/2025 (Estimated)
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/A0.00N/AN/AN/AN/A8/11/2025 (Estimated)
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
$1.14B$0.4335.4914.40N/A1.43%6.89%2.47%7/10/2025 (Estimated)

Latest SBMFF, OLCLY, SVNDY, and DNZOY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/28/2025Q4 2025
Oriental Land stock logo
OLCLY
Oriental Land
N/A$0.11N/A$0.11$1.22 billion$1.14 billion
4/25/2025Q4 2025
Denso Corp. stock logo
DNZOY
Denso
$0.29$0.25-$0.04$0.25$1,829.26 billion$13.01 billion
4/9/2025Q4 2025
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
$0.23$0.12-$0.11$0.27$18.47 billion$19.70 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Denso Corp. stock logo
DNZOY
Denso
$0.312.36%N/A32.29%N/A
Oriental Land stock logo
OLCLY
Oriental Land
$0.030.14%N/A6.00%N/A
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/AN/AN/A
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
$0.191.25%N/A44.19%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Denso Corp. stock logo
DNZOY
Denso
0.09
1.85
1.28
Oriental Land stock logo
OLCLY
Oriental Land
0.23
2.20
2.07
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/AN/AN/A
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
0.77
0.85
0.76

Institutional Ownership

CompanyInstitutional Ownership
Denso Corp. stock logo
DNZOY
Denso
N/A
Oriental Land stock logo
OLCLY
Oriental Land
N/A
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/A
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
0.01%

Insider Ownership

CompanyInsider Ownership
Denso Corp. stock logo
DNZOY
Denso
N/A
Oriental Land stock logo
OLCLY
Oriental Land
N/A
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
N/A
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Denso Corp. stock logo
DNZOY
Denso
162,0292.91 billionN/ANot Optionable
Oriental Land stock logo
OLCLY
Oriental Land
9,7191.80 billionN/ANot Optionable
Sino Biopharmaceutical stock logo
SBMFF
Sino Biopharmaceutical
25,80618.79 billionN/ANot Optionable
Seven and I Holdings Co. stock logo
SVNDY
Seven and I
47,8142.60 billionN/ANot Optionable

Recent News About These Companies

Understanding Seven Eleven: A Lot To Unlock
Best Value Stocks to Buy for May 16th
Couche-Tard signs NDA with 7-Eleven

New MarketBeat Followers Over Time

Media Sentiment Over Time

Denso stock logo

Denso OTCMKTS:DNZOY

$13.11 -0.21 (-1.58%)
As of 06/20/2025 03:59 PM Eastern

DENSO Corporation engages in the manufacture and sale of automotive parts in Japan, rest of Asia, North America, Europe, and internationally. The company offers air-conditioning systems, including thermal management heat pump system, heat pump air-conditioning systems, refrigerant products, personal heating and cooling devices, air quality system, heat exchangers, bus air-conditioning systems, automotive freezers, and cooling products, as well as heating, ventilation, and air-conditioning units. It also provides gasoline, diesel, hybrid, electric vehicle, and fuel cell vehicle power-train systems; and safety and cockpit systems, such as driving environment recognition, vehicle dynamic control, collision safety, visibility support, cockpit information, and information security systems, as well as other products. In addition, the company offers automotive service parts and accessories, comprising spark plugs, oil and cabin air filters, wiper blades, air filter elements, starters, alternators, compressors, oxygen sensors, fuel pumps, air conditioner service parts, radiators, condensers, ion generators, air conditioners for busses and construction vehicles, and truck refrigeration products, as well as refrigerant recovery, recycling, and charging machines; and repair and support products and services. Further, it provides industrial solutions for factories in automotive parts production; agricultural solutions, including Profarm Controller, a climate control system for greenhouse and horticulture solutions; and household air conditioning equipment and industrial systems. The company was incorporated in 1949 and is headquartered in Kariya, Japan.

Oriental Land stock logo

Oriental Land OTCMKTS:OLCLY

$21.84 -0.98 (-4.29%)
As of 06/20/2025 03:50 PM Eastern

Oriental Land Co., Ltd. operates and manages theme parks and hotels in Japan. It operates through Theme Park, Hotel Business, and Other Business segments. The Theme Park segment operates and manages Tokyo Disneyland and Tokyo DisneySea theme parks. The Hotel Business segment operates and manages Tokyo Disneyland Hotel, Tokyo DisneySea Hotel MiraCosta, Disney Ambassador Hotel, and Tokyo Disney Celebration Hotel, as well as Tokyo Disney Resort Toy Story Hotel. The Other Business segment operates and manages Ikspiari, a shopping complex that includes shops and restaurants, and a cinema complex; and Disney Resort Line, a monorail connecting four stations within Tokyo Disney Resort. It is also involved in the land development. Oriental Land Co., Ltd. was incorporated in 1960 and is based in Urayasu, Japan.

Sino Biopharmaceutical stock logo

Sino Biopharmaceutical OTCMKTS:SBMFF

$0.64 0.00 (-0.64%)
As of 06/18/2025 09:42 AM Eastern

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand. It also provides surgery/analgesia medicines, including flurbiprofen cataplasms under the brand Zepolas, limaprost tablets under the brand Kailitong, and recombinant human coagulation factor VIII for injection under the brand Anhengji; cardio-cerebral vascular medicines, such as irbesartan and hydrochlorothiazide tablets under the brand Yilunping and beraprost sodium tablets under the brand Kaina; and biosimilar medicines comprising adalimumab solution for injection under the brand Taibowei. In addition, the company develops oncology drugs, include benmelstobart, D-1553, TQ-B3139, and TQ-B3101; liver disease drugs, such as Lanifibranor and TQA2225/AP025; respiratory system drugs comprising TDI01, TQC2731, TCR1672, TQC3721, and TQH2722; and surgery/analgesia drugs, including PL-5, an antimicrobial peptide. Further, it is involved in the long-term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Seven and I stock logo

Seven and I OTCMKTS:SVNDY

$15.26 -0.11 (-0.72%)
As of 06/20/2025 03:55 PM Eastern

Seven & i Holdings Co., Ltd. operates convenience stores, superstores, department stores, supermarkets, and specialty stores. It operates through six segments: Domestic Convenience Store operations, Overseas Convenience Store Operations, Superstore Operations, Department and Specialty Store Operations, Financial Services, and Others. The company engages in the operation of convenience stores comprising directly managed corporate stores and franchised stores; retail business that provides daily life necessities, such as food and other daily necessities and dollar merchandise and services; banking, leasing, and credit card business; and real estate business. Seven & i Holdings Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.